Top 20 Biopharma Companies of 2025

Shots: Driven by innovation and a steadfast commitment to advancing cutting-edge therapies, the biopharma industry experienced robust growth in 2024, marked by significant revenue milestones With a projected compound annual growth rate (CAGR) of 12.87%, the global biopharma market is expected to reach $1.41 trillion by 2032. In 2024, Pfizer led the industry with total…

ByPrince GiriApril 24, 2025

THOUGHTSPOT

Keeping Up with Recent Diabetes Therapies (Diabetes Mellitus)

Shots:With an incurable nature and hefty medication costs, diabetes mellitus remains a global health concern and the seventh leading cause of death across the world. The 2021 data reflects 537M affected people, with the predominant population living in low- and middle-income countriesType 2 diabetes mellitus (T2DM), unlike Type 1 diabetes mellitus (T1DM) is…

BySaurabh ChaubeyApril 13, 2023

VIEWPOINTS

Leonard Glass, Vice President, Global Medical Affairs at Eli Lilly & Co. Shares Insights from Lilly’s Vision on New Stage of Metabolic Science

Shots:Leonard spoke about how Lilly is advancing in the field of metabolic disease research (esp. diabetes)He also talked about its lead candidate in type 2 diabetes and also discussed its clinical results in detailThe interview summarizes Lilly’s objective to advance new discoveries and redefine diabetes careSmriti: Tell us how Lilly is leading…

BySenior EditorAugust 16, 2022

Top 20 Biopharma Companies of 2025

Keeping Up with Recent Diabetes Therapies (Diabetes Mellitus)

Leonard Glass, Vice President, Global Medical Affairs at Eli Lilly & Co. Shares Insights from Lilly’s Vision on New Stage of Metabolic Science

Contact US

OUR INFORMATION

FOLLOW US